Composition and kit for distinguishing between mild Alzheimer's disease and moderate Alzheimer's disease using nasal fluid

摘要

The present invention is a composition for screening progression stages of Alzheimer''s disease, including kits for measuring beta amyloid oligomers and S100A9 protein expression levels in a runny nose samples, kits and runny nose expression levels of beta amyloid oligomers and S100A9 protein It relates to a method for screening progression of Alzheimer''s disease comprising the step of measuring. The present invention also includes a method for screening a mild Alzheimer''s disease therapeutic agent comprising the step of measuring the expression level of beta amyloid oligomer and S100A9 protein in a runny nose sample and an agent for measuring the expression level of beta amyloid oligomer and S100A9 protein in a runny nose sample. The present invention relates to a screening kit for treating a mild Alzheimer''s disease.